VSV encoding the IFNβ transgene (VSV-IFNβ) is capable of preventing tumor growth through multiple mechanisms, such as triggering direct cell killing, stimulating innate immune response, recruiting CD8 T-cells, and depleting T-regulatory cells [155]. The gene discussed is IFNB1; the disease is neoplasm.